Investment
Features
FeesSafety
Academy
More
Pluang+

Bank of America rates Diodes a buy, forecasting 58% annual EPS growth through 2028, outpacing peers.

Analyst Insights
06 Oct 2026
Proactive Investors
View Source
Bullish
Bank of America rates Diodes a buy, forecasting 58% annual EPS growth through 2028, outpacing peers.

Bank of America initiated a buy rating on Diodes, an analog semiconductor supplier, with a $135 price target. The bank expects Diodes to grow earnings per share at a 58% annual rate from 2026 to 2028, significantly higher than the 35% forecast for its analog chip peers. Diodes, which makes chips used in automotive, servers, and factories, is set to benefit from rising content per vehicle and expanding AI data center sales. Despite some risks from competition and its hybrid manufacturing model, the company’s shares rose over 6% following the upgrade.

Diodes' earnings growth is projected to outpace its analog semiconductor peers with a 58% annual rate from 2026 to 2028, according to Bank of America. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 06, 2026 22:41 WIB: out of 150 priced US tech stocks, 93 rose and 54 fell. Notable movers include AEHR at USD 98.63 with a 5.53% decline and a typical hold time of 15 days, GLW at USD 168.11 up 5.48% with a 35-day hold, and NOK at USD 10.74 up 5.34% with a 66-day hold.

More News

Stryker stock drops 8.8% on unresolved manufacturing issues despite strong growth outlook

Stryker stock drops 8.8% on unresolved manufacturing issues despite strong growth outlook

Stryker experienced an 8.8% stock drop on September 8, 2026, wiping out over $10 billion in market value due to ongoing manufacturing problems that were thought resolved. Truist Financial lowered its price target from $340 to $310, reflecting concern...

Market News
Neutral
1 hour ago
Bank OZK to report Q3 2026 earnings on Oct 20 amid Citigroup's Sell rating at $45.59

Bank OZK to report Q3 2026 earnings on Oct 20 amid Citigroup's Sell rating at $45.59

Bank OZK is scheduled to release its Q3 2026 earnings after market close on October 20, providing investors with updated financial results to compare against Citigroup's current Sell rating. The bank's latest balance sheet shows $41.70 billion in tot...

Company Fundamentals
Neutral
1 hour ago
Scotiabank raises Pfizer price target to $33, signaling 20.9% potential gain.

Scotiabank raises Pfizer price target to $33, signaling 20.9% potential gain.

Scotiabank has increased its price target for Pfizer stock from $30.00 to $33.00, suggesting a potential upside of 20.9% from the current trading price of $27.31. Pfizer, a major pharmaceutical company, holds a strong buy rating with a Zacks Rank of ...

Analyst Insights
Bullish
2 hours ago
Citigroup raises AstraZeneca price target after strong clinical trial results

Citigroup raises AstraZeneca price target after strong clinical trial results

Citigroup has raised its price target for AstraZeneca to £186.00 from £178.00, maintaining a Buy rating following successful Phase 3 clinical trials. The increase reflects higher peak sales forecasts for drugs tozorakimab and SERENA-6, offsetting the...

Analyst Insights
Bullish
2 hours ago
Devon Energy shares seen rising 40% as analyst sets $67 price target amid asset sale pressures.

Devon Energy shares seen rising 40% as analyst sets $67 price target amid asset sale pressures.

An analyst from BMO Capital set a $67 price target for Devon Energy, suggesting a 40% upside from its current share price of around $48. The oil and gas producer has consistently beaten earnings estimates recently, showing strong financial health. Ho...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App